Inhibikase Therapeutics, Inc. - Common Stock (IKT)

2.0100
+0.0800 (4.15%)
NASDAQ · Last Trade: May 7th, 2:50 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors